Valued at USD 3.50 Billion in 2024, the global biosimulation market is projected to reach USD 16.68 Billion by 2034, growing at a CAGR of 16.90%. Asia Pacific holds a significant share, with advancements in biosimulation technologies driving market expansion. https://www.expertmarketresearch.com/reports/asia-pacific-biosimulation-market